-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group’s Bosheng Medical Devices Selected for the MIIT’s 5G Factory Directory
Category:
发布时间：2025-09-10
【概要描述】
On September 4, the General Office of the Ministry of Industry and Information Technology released the “2025 5G Factory Directory,” in which the Group’s Boshi Medical Materials’ “Multi-layer Co-extruded Biomedical Film 5G Factory” was successfully selected thanks to its remarkable achievements in the deep integration of 5G technology with the industrial internet. This milestone signifies that the company has received national-level recognition in the field of intelligent manufacturing of pharmaceutical packaging materials.
On September 4, the General Office of the Ministry of Industry and Information Technology released the “2025 5G Factory Directory,” in which the Group’s Bosun Medical Materials’ “Multi-layer Co-extruded Biomedical Film 5G Factory” was successfully selected thanks to its remarkable achievements in the deep integration of 5G technology with the industrial internet. This marks a national-level recognition of the company’s expertise in intelligent manufacturing of pharmaceutical packaging materials.
According to reports, a 5G factory refers to an advanced manufacturing facility that leverages next-generation information and communication technologies—with 5G as the flagship—to transform existing production lines, workshops, and plants or to build new ones from the ground up, all underpinned by industrial Internet infrastructure. By integrating digital technologies such as 5G and artificial intelligence into industrial production environments, these factories achieve extensive connectivity among production units, full utilization of data as a key production factor, and efficient enablement of innovative applications. The selection of 5G factories is a crucial initiative for deepening the innovative development of “5G + Industrial Internet,” accelerating the cultivation and construction of high-level 5G factories, and driving the transformation and upgrading of China’s traditional industries.
The newly released “2025 5G Factory Directory” showcases the latest achievements in the deep integration of 5G technology and manufacturing in China, setting a benchmark for digital transformation across the industry. Within the pharmaceutical manufacturing category of the directory, 15 enterprises nationwide were selected, including Boson Medical’s “Multi-layer Co-extruded Biomaterial Membrane 5G Factory” project. This marks another groundbreaking milestone in intelligent and digital transformation, following the company’s earlier recognition as an Advanced-Level Smart Factory in Jiangsu Province and a Jiangsu Provincial Intelligent Manufacturing Workshop.
The “5G-enabled Multi-layer Co-extruded Biomaterial Membrane Factory” project developed by Bosheng Medical Devices is built on a core architecture of “5G + Industrial Internet.” Centered on integrated production quality control and supply-chain collaboration, the project has implemented digital solutions across various operational scenarios, establishing an intelligent manufacturing model that covers the entire production process, all aspects of management, and the full product lifecycle. This approach has effectively achieved deep integration between information flows and production workflows, significantly enhancing both production efficiency and quality-control capabilities for multi-layer co-extruded biomaterial membranes. As a result, these products are increasingly favored by the pharmaceutical industry, with their market share steadily rising.
“Being selected as a 5G Factory is both a recognition and affirmation of our company’s achievements in digital transformation, as well as a powerful incentive and driving force for future development,” said the head of Bosheng Medical Devices. Moving forward, Bosheng will continue to focus on the practical application of 5G innovations, using smart manufacturing as a key breakthrough to steadily expand the scope of 5G applications across its pharmaceutical packaging materials facilities and drive the high-end, intelligent upgrade of the manufacturing sector. By comprehensively enhancing quality control throughout the production process of co-extruded films, rubber stoppers, and other pharmaceutical packaging materials, the company will accelerate the intelligent transformation of its entire production and operations value chain, injecting new momentum into its pursuit of high-quality growth.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091